Company Filing History:
Years Active: 2013
Title: **Innovator Spotlight: Arundhati S Deo**
Introduction
Arundhati S Deo is an accomplished inventor based in Saint Paul, MN, who has made significant contributions to the field of pharmaceuticals. With a focus on developing innovative treatments, Deo's work is particularly noteworthy in the realm of mental health and associated disorders.
Latest Patents
Deo holds a patent for a novel invention that provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I, which serve as selective 5-HT receptor agonists. This invention is designed for the treatment of various 5-HT associated disorders, including obesity, obsessive-compulsive disorder, depression, and anxiety. The patent highlights her commitment to addressing critical health issues through innovative pharmacological solutions.
Career Highlights
Currently, Arundhati S Deo is employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role involves collaborating on research and development projects aimed at creating effective medications that improve patient outcomes in mental health.
Collaborations
Deo has collaborated with notable colleagues such as John Gordon Allen and Karin Briner, further enhancing the collaborative environment at Eli Lilly. These partnerships exemplify the team's commitment to innovation and progress in the pharmaceutical industry.
Conclusion
Through her innovative work and dedication, Arundhati S Deo signifies the impact of inventors in the healthcare sector. Her patent reflects a promising advancement in treating mental health disorders, exemplifying the role of creativity and science in developing solutions for better health outcomes. As she continues her work, Deo remains an inspiring figure in the realm of pharmaceutical innovation.